Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03234712
Title A Study Evaluating the Safety, Pharmacokinetics, and Anti-tumor Activity of ABBV-321 in Subjects With Advanced Solid Tumors Associated With Overexpression of the Epidermal Growth Factor Receptor (EGFR) or Its Ligands
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors AbbVie
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | AUS

Facility Status City State Zip Country Details
Highlands Oncology Group /ID# 166132 Springdale Arkansas 72762 United States Details
The Angeles Clinic and Researc /ID# 166133 Los Angeles California 90025 United States Details
University of California, Davis Comprehensive Cancer Center /ID# 215012 Sacramento California 95817 United States Details
Northwestern University Feinberg School of Medicine /ID# 165191 Chicago Illinois 60611-2927 United States Details
University of Chicago /ID# 166064 Chicago Illinois 60637 United States Details
Northshore University Health System Dermatology Clinical Trials Unit /ID# 201095 Skokie Illinois 60077 United States Details
University of Kentucky Markey Cancer Center /ID# 217665 Lexington Kentucky 40536-7001 United States Details
Dana-Farber Cancer Institute /ID# 212920 Boston Massachusetts 02215 United States Details
Washington University-School of Medicine /ID# 214955 Saint Louis Missouri 63110 United States Details
Columbia Univ Medical Center /ID# 167184 New York New York 10032-3725 United States Details
Stony Brook University Hospital /ID# 216976 Stony Brook New York 11794-8183 United States Details
Duke University Medical Center /ID# 166135 Durham North Carolina 27710-3000 United States Details
Lifespan Cancer Institute at Rhode Island Hospital /ID# 168600 Providence Rhode Island 02903-4923 United States Details
South Texas Accelerated Research Therapeutics /ID# 166134 San Antonio Texas 78229 United States Details
Northern Cancer Institute /ID# 166138 St Leonards New South Wales 2065 Australia Details
Monash Health /ID# 217435 Clayton Victoria 3168 Australia Details
Austin Hospital /ID# 166137 Heidelberg Victoria 3084 Australia Details
Sheba Medical Center /ID# 166398 Ramat Gan 5239424 Israel Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field